Industry giant plans to deliver new COVID treatment to Australia – NEWS.com.au

Pharmaceuticals behemoth GlaxoSmithKline hopes to launch its maiden coronavirus treatment and, if all goes well, it will be destined for Australia.The multibillion-dollar industry giant has received a “provisional determination” from the Therapeutic Goods Administration (TGA) for an antibody treatment called Sotrovimab.
“This allows the sponsor to apply for registration under this pathway. This is not an approval,” a TGA spokesperson told NCA NewsWire.
“If the TGA finds that this therapeutic is…

Click here to view the original article.